{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T03:15:07Z","timestamp":1794885307108,"version":"4.9.1"},"reference-count":32,"publisher":"American Society of Hematology","issue":"22","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,11,25]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>Hepatotoxicity is a well-documented complication of induction chemotherapy for acute lymphoblastic leukemia (ALL), but our understanding of its biological mechanisms is limited. We identified 314 patients with ALL (aged 1-19 years) treated at Texas Children\u2019s Hospital (2008-2019) with diagnostic bone marrow plasma available for metabolomic profiling: 234 for discovery and 80 for replication. Hepatotoxicity during induction was defined as follows: (1) transaminitis: grade \u22653 aspartate aminotransferase or alanine aminotransferase or (2) conjugated hyperbilirubinemia: conjugated bilirubin (c.bili) &amp;gt;3 mg\/dL. Untargeted profiling detected 519 metabolites. Adjusted odds ratios (aORs) for each metabolite were calculated with logistic regression, accounting for sex, age, body mass index, race\/ethnicity, and treatment intensity. The population was 56% Latino, 57% male, 92% B-ALL, 25% overweight\/obese, and 57% National Cancer Institute standard-risk at a median age of 5 years. Transaminitis was observed in 34% of the discovery and 24% of the replication cohort. Seven instances of c.bili &amp;gt;3 mg\/dL were observed in the discovery cohort, with none in the replication cohort. Furthermore, 12 metabolites were associated with transaminitis (P &amp;lt; .05) in the discovery cohort, including 2 that replicated (P &amp;lt; .05): 1,2-dipalmitoyl-glycerophosphocholine (GPC) (aOR combined = 1.88 [95% confidence interval [CI], 1.26-2.79], P = .002) and 1-(1-enyl-palmitoyl)-2-palmitoleoyl-GPC (aOR combined = 1.56 [95% CI: 1.17-2.09], P = .003). In the discovery cohort, 34 metabolites were associated with c.bili &amp;gt;3 mg\/dL, including the top association of 1,2-dipalmitoyl-GPC (aOR = 5.76 [95% CI: 2.20-23.16], P = .002). We observed and replicated associations between phosphatidylcholine metabolites at ALL diagnosis and hepatotoxicity during induction therapy, suggesting a potential role for lipid dysregulation in the development of hepatotoxicity.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1182\/bloodadvances.2025016978","type":"journal-article","created":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T20:07:02Z","timestamp":1755634022000},"page":"5802-5810","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":3,"title":["An analysis of diagnostic metabolomic profiles associated with hepatotoxicity during childhood ALL induction therapy"],"prefix":"10.1182","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8120-2138","authenticated-orcid":false,"given":"Emily J.","family":"Mason","sequence":"first","affiliation":[{"name":"1Department of Pediatrics, Baylor College of Medicine, Houston, TX"},{"name":"2Department of Cancer and Hematology Center, Texas Children's Hospital, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna M.","family":"Crain","sequence":"additional","affiliation":[{"name":"1Department of Pediatrics, Baylor College of Medicine, Houston, TX"},{"name":"2Department of Cancer and Hematology Center, Texas Children's Hospital, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael E.","family":"Scheurer","sequence":"additional","affiliation":[{"name":"1Department of Pediatrics, Baylor College of Medicine, Houston, TX"},{"name":"2Department of Cancer and Hematology Center, Texas Children's Hospital, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0978-5863","authenticated-orcid":false,"given":"Philip J.","family":"Lupo","sequence":"additional","affiliation":[{"name":"1Department of Pediatrics, Baylor College of Medicine, Houston, TX"},{"name":"2Department of Cancer and Hematology Center, Texas Children's Hospital, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4081-8195","authenticated-orcid":false,"given":"Karen R.","family":"Rabin","sequence":"additional","affiliation":[{"name":"1Department of Pediatrics, Baylor College of Medicine, Houston, TX"},{"name":"2Department of Cancer and Hematology Center, Texas Children's Hospital, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga A.","family":"Taylor","sequence":"additional","affiliation":[{"name":"1Department of Pediatrics, Baylor College of Medicine, Houston, TX"},{"name":"2Department of Cancer and Hematology Center, Texas Children's Hospital, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marley","family":"Roberts","sequence":"additional","affiliation":[{"name":"1Department of Pediatrics, Baylor College of Medicine, Houston, TX"},{"name":"2Department of Cancer and Hematology Center, Texas Children's Hospital, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John P.","family":"Woodhouse","sequence":"additional","affiliation":[{"name":"1Department of Pediatrics, Baylor College of Medicine, Houston, TX"},{"name":"2Department of Cancer and Hematology Center, Texas Children's Hospital, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-7986-601X","authenticated-orcid":false,"given":"Ashley","family":"Chavana","sequence":"additional","affiliation":[{"name":"1Department of Pediatrics, Baylor College of Medicine, Houston, TX"},{"name":"2Department of Cancer and Hematology Center, Texas Children's Hospital, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen","family":"Ludwig","sequence":"additional","affiliation":[{"name":"3Department of Pediatrics, UT Southwestern Medical Center, Dallas, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1323-7720","authenticated-orcid":false,"given":"Laura","family":"Klesse","sequence":"additional","affiliation":[{"name":"3Department of Pediatrics, UT Southwestern Medical Center, Dallas, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth","family":"Heym","sequence":"additional","affiliation":[{"name":"4Hematology and Oncology Center, Cook Children's Hospital, Fort Worth, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"Griffin","sequence":"additional","affiliation":[{"name":"5Division of Pediatric Hematology\/Oncology, Children's Hospital of San Antonio, San Antonio, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo","family":"Erana","sequence":"additional","affiliation":[{"name":"2Department of Cancer and Hematology Center, Texas Children's Hospital, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Carlos","family":"Bernini","sequence":"additional","affiliation":[{"name":"2Department of Cancer and Hematology Center, Texas Children's Hospital, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Monica","family":"Gramatges","sequence":"additional","affiliation":[{"name":"1Department of Pediatrics, Baylor College of Medicine, Houston, TX"},{"name":"2Department of Cancer and Hematology Center, Texas Children's Hospital, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0914-8728","authenticated-orcid":false,"given":"Joanna S.","family":"Yi","sequence":"additional","affiliation":[{"name":"1Department of Pediatrics, Baylor College of Medicine, Houston, TX"},{"name":"2Department of Cancer and Hematology Center, Texas Children's Hospital, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1007-9176","authenticated-orcid":false,"given":"Sandi L.","family":"Pruitt","sequence":"additional","affiliation":[{"name":"6Department of Population and Data Sciences, Harold C. Simmons Comprehensive Cancer Center, Dallas, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9612-3624","authenticated-orcid":false,"given":"M. Brooke","family":"Bernhardt","sequence":"additional","affiliation":[{"name":"7Department of Pharmacy and Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, TN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8562-3351","authenticated-orcid":false,"given":"Hong","family":"Zhu","sequence":"additional","affiliation":[{"name":"8Division of Biostatistics, University of Virginia School of Medicine, Charlottesville, VA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2867-1298","authenticated-orcid":false,"given":"Steven D.","family":"Mittelman","sequence":"additional","affiliation":[{"name":"9Department of Pediatric Endocrinology, University of California, Los Angeles, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Van","family":"Huynh","sequence":"additional","affiliation":[{"name":"10Hyundai Cancer Instititue, Children's Hospital of Orange County, Orange, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1487-6818","authenticated-orcid":false,"given":"Etan","family":"Orgel","sequence":"additional","affiliation":[{"name":"11Cancer and Blood Disease Institute, Children's Hospital of Los Angeles, Los Angeles, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy M.","family":"Schraw","sequence":"additional","affiliation":[{"name":"1Department of Pediatrics, Baylor College of Medicine, Houston, TX"},{"name":"2Department of Cancer and Hematology Center, Texas Children's Hospital, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5802-5073","authenticated-orcid":false,"given":"Austin L.","family":"Brown","sequence":"additional","affiliation":[{"name":"1Department of Pediatrics, Baylor College of Medicine, Houston, TX"},{"name":"2Department of Cancer and Hematology Center, Texas Children's Hospital, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2025,11,16]]},"reference":[{"issue":"1","key":"2025112509013300200_bib1","first-page":"17","article-title":"Cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J Clin"},{"issue":"11","key":"2025112509013300200_bib2","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/S1470-2045(10)70114-5","article-title":"Glucocorticoid use in acute lymphoblastic leukaemia","volume":"11","author":"Inaba","year":"2010","journal-title":"Lancet Oncol"},{"issue":"1","key":"2025112509013300200_bib3","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.pcl.2014.09.006","article-title":"Treatment of pediatric acute lymphoblastic leukemia","volume":"62","author":"Cooper","year":"2015","journal-title":"Pediatr Clin North Am"},{"issue":"12","key":"2025112509013300200_bib4","doi-asserted-by":"crossref","first-page":"5477","DOI":"10.1182\/blood-2008-01-132837","article-title":"Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia and its relationship to other prognostic factors: a Children's Oncology Group study","volume":"111","author":"Borowitz","year":"2008","journal-title":"Blood"},{"issue":"4","key":"2025112509013300200_bib5","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/mpo.2950070415","article-title":"Hepatotoxicity in the treatment of acute lymphoblastic leukaemia","volume":"7","author":"Topley","year":"1979","journal-title":"Med Pediatr Oncol"},{"key":"2025112509013300200_bib6","doi-asserted-by":"crossref","first-page":"444","DOI":"10.12688\/f1000research.10768.1","article-title":"Non-infectious chemotherapy-associated acute toxicities during childhood acute lymphoblastic leukemia therapy","volume":"6","author":"Schmiegelow","year":"2017","journal-title":"F1000Res"},{"issue":"21","key":"2025112509013300200_bib7","doi-asserted-by":"crossref","first-page":"7551","DOI":"10.1002\/cam4.4281","article-title":"Levocarnitine for pegaspargase-induced hepatotoxicity in older children and young adults with acute lymphoblastic leukemia","volume":"10","author":"Schulte","year":"2021","journal-title":"Cancer Med"},{"issue":"2","key":"2025112509013300200_bib8","first-page":"95","article-title":"Hepatotoxicity secondary to chemotherapy","volume":"2","author":"Grigorian","year":"2014","journal-title":"J Clin Transl Hepatol"},{"issue":"1","key":"2025112509013300200_bib9","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1053\/j.seminoncol.2005.11.002","article-title":"Hepatotoxicity of chemotherapy","volume":"33","author":"Floyd","year":"2006","journal-title":"Semin Oncol"},{"issue":"5","key":"2025112509013300200_bib10","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.3324\/haematol.2021.279805","article-title":"A report from the Leukemia Electronic Abstraction of Records Network on risk of hepatotoxicity during pediatric acute lymphoblastic leukemia treatment","volume":"107","author":"Yi","year":"2022","journal-title":"Haematologica"},{"issue":"2","key":"2025112509013300200_bib11","doi-asserted-by":"crossref","first-page":"e28063","DOI":"10.1002\/pbc.28063","article-title":"Incidence and predictors of treatment-related conjugated hyperbilirubinemia during early treatment phases for children with acute lymphoblastic leukemia","volume":"67","author":"Hashmi","year":"2020","journal-title":"Pediatr Blood Cancer"},{"issue":"3","key":"2025112509013300200_bib12","doi-asserted-by":"crossref","first-page":"e26891","DOI":"10.1002\/pbc.26891","article-title":"Predictors of hepatotoxicity and pancreatitis in children and adolescents with acute lymphoblastic leukemia treated according to contemporary regimens","volume":"65","author":"Denton","year":"2018","journal-title":"Pediatr Blood Cancer"},{"key":"2025112509013300200_bib13","doi-asserted-by":"crossref","first-page":"113000","DOI":"10.1016\/j.biopha.2022.113000","article-title":"Hispanic ethnicity and the rs4880 variant in SOD2 are associated with elevated liver enzymes and bilirubin levels in children receiving asparaginase-containing chemotherapy for acute lymphoblastic leukemia","volume":"150","author":"Wu","year":"2022","journal-title":"Biomed Pharmacother"},{"issue":"3","key":"2025112509013300200_bib14","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1080\/10428194.2017.1349902","article-title":"PEGging down risk factors for peg-asparaginase hepatotoxicity in patients with acute lymphoblastic leukemia\u2020","volume":"59","author":"Rausch","year":"2018","journal-title":"Leuk Lymphoma"},{"issue":"7","key":"2025112509013300200_bib15","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1200\/JCO.19.02292","article-title":"Individualized asparaginase dosing in childhood acute lymphoblastic leukemia","volume":"38","author":"Kloos","year":"2020","journal-title":"J Clin Oncol"},{"issue":"3","key":"2025112509013300200_bib16","doi-asserted-by":"crossref","first-page":"76","DOI":"10.4239\/wjd.v1.i3.76","article-title":"Metabolic effects of obesity: a review","volume":"1","author":"Singla","year":"2010","journal-title":"World J Diabetes"},{"issue":"1","key":"2025112509013300200_bib17","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s12902-019-0366-3","article-title":"Metabolic syndrome and liver-related events: a systematic review and meta-analysis","volume":"19","author":"Ren","year":"2019","journal-title":"BMC Endocr Disord"},{"issue":"1","key":"2025112509013300200_bib18","doi-asserted-by":"crossref","first-page":"a000588","DOI":"10.1101\/mcs.a000588","article-title":"Metabolomics: an emerging but powerful tool for precision medicine","volume":"1","author":"Clish","year":"2015","journal-title":"Cold Spring Harb Mol Case Stud"},{"issue":"1","key":"2025112509013300200_bib19","doi-asserted-by":"crossref","first-page":"19613","DOI":"10.1038\/s41598-021-99147-6","article-title":"Comparison of the blood, bone marrow, and cerebrospinal fluid metabolomes in children with b-cell acute lymphoblastic leukemia","volume":"11","author":"Schraw","year":"2021","journal-title":"Sci Rep"},{"key":"2025112509013300200_bib20","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ebiom.2019.09.033","article-title":"Metabolomic profiling identifies pathways associated with minimal residual disease in childhood acute lymphoblastic leukaemia","volume":"48","author":"Schraw","year":"2019","journal-title":"EBioMedicine"},{"issue":"7","key":"2025112509013300200_bib21","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1002\/hep4.1188","article-title":"Metabolomic-based noninvasive serum test to diagnose nonalcoholic steatohepatitis: Results from discovery and validation cohorts","volume":"2","author":"Mayo","year":"2018","journal-title":"Hepatol Commun"},{"issue":"3","key":"2025112509013300200_bib22","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/mpo.2950140317","article-title":"Report and recommendations of the Rome workshop concerning poor-prognosis acute lymphoblastic leukemia in children: biologic bases for staging, stratification, and treatment","volume":"14","author":"Mastrangelo","year":"1986","journal-title":"Med Pediatr Oncol"},{"issue":"1","key":"2025112509013300200_bib23","first-page":"92","article-title":"Multivariate analysis in metabolomics","volume":"1","author":"Worley","year":"2013","journal-title":"Curr Metabolomics"},{"issue":"Web server issue","key":"2025112509013300200_bib24","doi-asserted-by":"crossref","first-page":"W71","DOI":"10.1093\/nar\/gkq329","article-title":"MSEA: a web-based tool to identify biologically meaningful patterns in quantitative metabolomic data","volume":"38","author":"Xia","year":"2010","journal-title":"Nucleic Acids Res"},{"issue":"W1","key":"2025112509013300200_bib25","doi-asserted-by":"crossref","first-page":"W388","DOI":"10.1093\/nar\/gkab382","article-title":"MetaboAnalyst 5.0: narrowing the gap between raw spectra and functional insights","volume":"49","author":"Pang","year":"2021","journal-title":"Nucleic Acids Res"},{"issue":"5","key":"2025112509013300200_bib26","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.2337\/db12-0707","article-title":"Early metabolic markers of the development of dysglycemia and type 2 diabetes and their physiological significance","volume":"62","author":"Ferrannini","year":"2013","journal-title":"Diabetes"},{"issue":"10","key":"2025112509013300200_bib27","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1016\/j.hpb.2019.02.008","article-title":"Metabolomic profiling highlights the metabolic bases of acute-on-chronic and post-hepatectomy liver failure","volume":"21","author":"Faitot","year":"2019","journal-title":"HPB (Oxford)"},{"issue":"5","key":"2025112509013300200_bib28","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1053\/j.gastro.2020.07.019","article-title":"Serum levels of metabolites produced by intestinal microbes and lipid moieties independently associated with acute-on-chronic liver failure and death in patients with cirrhosis","volume":"159","author":"Bajaj","year":"2020","journal-title":"Gastroenterology"},{"issue":"1","key":"2025112509013300200_bib29","doi-asserted-by":"crossref","first-page":"138","DOI":"10.3109\/10428194.2015.1136741","article-title":"Limitations of body mass index to assess body composition due to sarcopenic obesity during leukemia therapy","volume":"59","author":"Orgel","year":"2018","journal-title":"Leuk Lymphoma"},{"issue":"7","key":"2025112509013300200_bib30","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1182\/bloodadvances.2020004018","article-title":"Caloric and nutrient restriction to augment chemotherapy efficacy for acute lymphoblastic leukemia: the IDEAL trial","volume":"5","author":"Orgel","year":"2021","journal-title":"Blood Adv"},{"issue":"5","key":"2025112509013300200_bib31","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1042\/BCJ20170604","article-title":"Metabolic profiling of visceral adipose tissue from obese subjects with or without metabolic syndrome","volume":"475","author":"Candi","year":"2018","journal-title":"Biochem J"},{"issue":"2","key":"2025112509013300200_bib32","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1002\/(SICI)1097-0142(19980715)83:2<379::AID-CNCR24>3.0.CO;2-P","article-title":"Blood lipid profiles in children with acute lymphoblastic leukemia","volume":"83","author":"Halton","year":"1998","journal-title":"Cancer"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/9\/22\/5802\/2420419\/blooda_adv-2025-016978-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/9\/22\/5802\/2420419\/blooda_adv-2025-016978-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T14:01:42Z","timestamp":1764079302000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/9\/22\/5802\/546760\/An-analysis-of-diagnostic-metabolomic-profiles"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,16]]},"references-count":32,"journal-issue":{"issue":"22","published-print":{"date-parts":[[2025,11,25]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2025016978","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,11,25]]},"published":{"date-parts":[[2025,11,16]]}}}